These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9185392)

  • 21. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.
    Daw MA; Elkaber MA; Drah AM; Werfalli MM; Mihat AA; Siala IM
    Saudi Med J; 2002 Nov; 23(11):1356-60. PubMed ID: 12506296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.
    Amon JJ; Garfein RS; Ahdieh-Grant L; Armstrong GL; Ouellet LJ; Latka MH; Vlahov D; Strathdee SA; Hudson SM; Kerndt P; Des Jarlais D; Williams IT
    Clin Infect Dis; 2008 Jun; 46(12):1852-8. PubMed ID: 18462109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
    Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
    Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
    Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
    J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C antibodies in haemodialysis and pattern of end-stage renal failure in Gassim, Saudi Arabia.
    Soyannwo MA; Khan N; Kommajosyula S; Abdel Rahman AR; Khadaji M; Sing R; Laithy SU; Ladha A; Azzam A; Desmukh S
    Afr J Med Med Sci; 1996 Mar; 25(1):13-22. PubMed ID: 9110050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
    Idrees M; Lal A; Naseem M; Khalid M
    J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].
    Thierfelder W; Meisel H; Schreier E; Dortschy R
    Gesundheitswesen; 1999 Dec; 61 Spec No():S110-4. PubMed ID: 10726407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV activity in Calcutta--a serological study.
    Neogi DK; Bhattacharya N; Chakrabarti T; Mukherjee KK
    J Commun Dis; 1997 Mar; 29(1):1-6. PubMed ID: 9282522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
    Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
    Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
    Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
    J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users.
    Anastassopoulou CG; Paraskevis D; Sypsa V; Psichogiou M; Katsoulidou A; Tassopoulos N; Skoutelis A; Malliori M; Hatzakis A
    J Med Virol; 1998 Nov; 56(3):246-52. PubMed ID: 9783693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
    Fathalla SE; Al-Jama AA; Al-Sheikh IH; Islam SI
    Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal cocaine use does not appear to be an independent risk factor for HCV infection.
    Galperim B; Cheinquer H; Stein A; Fonseca A; Lunge V; Ikuta N
    Addiction; 2004 Aug; 99(8):973-7. PubMed ID: 15265094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.